Related Experiment Video
Updated: May 28, 2026
07:33
Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Cancer vaccines and carbohydrate epitopes
Jamie Heimburg-Molinaro1, Michelle Lum, Geraldine Vijay
1Department of Biochemistry, Emory University, Atlanta, GA 30322, United States.
Vaccine
|October 4, 2011
Summary
Tumor-associated carbohydrate antigens (TACAs) are key targets for cancer vaccines. Understanding their role in tumor growth and metastasis is crucial for developing effective T-independent immune responses against cancer.
Area of Science:
- Oncology
- Immunology
- Glycobiology
Background:
- Aberrant glycosylation leads to tumor-associated carbohydrate antigens (TACAs) on cancer cells.
- TACAs include mucin-related, blood group Lewis-related, glycosphingolipids, and gangliosides.
- Understanding T-independent immune responses is vital for cancer vaccine development.
Purpose of the Study:
- To review the role of TACAs in cancer growth and metastasis.
- To discuss vaccine development strategies targeting TACAs.
- To elucidate the T-independent immune response to carbohydrate antigens.
Main Methods:
- Review of literature on TACAs and their role in cancer.
- Analysis of T-independent immune responses to carbohydrate antigens.
- Examination of current cancer vaccine development efforts targeting TACAs.
Main Results:
- TACAs play significant roles in tumor growth and metastasis.
- Knowledge of T-independent immunity informs vaccine design.
- Various TACAs are being investigated as vaccine targets.
Conclusions:
- TACAs are promising targets for cancer immunotherapy.
- Targeting TACAs can potentially enhance anti-tumor immunity.
- Further research into TACA-specific immune responses is needed for effective vaccine strategies.
More Related Videos
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...